ALISO VIEJO, Calif., Feb. 29, 2024 RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today.
CEO Stephen C. Glover to discuss key updates on the development status of ZyVersa’s Phase 2a-ready Cholesterol Efflux Mediator™ VAR 200 for renal disease,.
SAN FRANCISCO, March 01, 2023 ProSomnus, Inc. , a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea , today announces that Company management will. | March 1, 2023
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.